The Institute for Biohealth Innovation harnesses the collective talent of more than 300 GMU faculty and staff and thousands of students across 34 academic departments. The IBI connects Mason researchers with potential collaborators, both within the university and externally, to take on some of biohealth’s biggest challenges. We bridge disciplines to promote progress and share innovation with the goal of enhancing health and well being through new ideas to predict, prevent, treat, and eradicate disease. Our portfolio consists of major research thrusts including cancer, infectious diseases, brain and behavior, injury and performance, reproductive and family health, cardiovascular and metabolic health, digital health and informatics, and policy and economics. The IBI provides a collaborative space that allows researchers to make novel connections and implement innovative solutions to today’s most pressing health issues.
The IBI’s researchers are spread across George Mason University’s campuses, located in Northern Virginia. Mason is situated in the Biohealth Capital Region (BHCR), a prominent biohealth cluster in the mid-Atlantic. BHCR is home to U.S. Federal agencies, including the NIH, NSF, and DOD, more than 800 life science companies and several accelerators to support start-ups, prominent healthcare systems, and world class academic and research institutions.
Check out our 2021 annual report down below: